Guardian Pharmacy Services reported cash from operations of $30.02M and free cash flow of $30.02M for the quarter ended Jun 2026, up 50.6% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -7.00M | 14.56M | 7.09M | 15.85M | -105.82M | 11.84M | 9.27M | 8.83M | 9.59M | 21.27M | 13.54M | 22.12M |
| Share-based CompensationStock Comp. | -22.72M | 5.95M | -0.27M | 122.36M | 3.46M | 3.97M | 4.45M | 4.36M | 1.08M | 1.86M | 2.93M | |
| Deferred Taxes | 2.36M | |||||||||||
| Asset Writedowns and ImpairmentWritedown | 1.36M | 1.40M | 1.74M | 1.11M | 2.13M | 0.90M | 1.01M | 1.21M | 1.47M | 1.06M | 1.78M | |
| Cash from OperationsCash from Ops. | 14.55M | 8.65M | 29.13M | -2.16M | 22.34M | 17.55M | 19.94M | 28.17M | 34.60M | 6.06M | 30.02M | |
| Depreciation, Depletion & Amortization | ||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 4.71M | 4.75M | 4.87M | 4.99M | 5.15M | 5.27M | 5.49M | 5.84M | 5.74M | 5.98M | 5.81M | |
| Change in Working Capital | ||||||||||||
| Change in ReceivablesChange Receivables | 2.34M | 9.54M | 5.61M | 2.13M | 8.20M | 1.01M | -2.59M | 13.18M | -3.04M | 11.13M | -6.25M | |
| Change in InventoryChange Inventory | -0.85M | 1.83M | -0.92M | 5.32M | -5.08M | 2.88M | -0.41M | 3.19M | -4.79M | 3.80M | 3.28M | |
| Change in Account PayablesChange Payables | -3.92M | 7.19M | 4.15M | 2.82M | -0.93M | 1.87M | 1.88M | 17.40M | -4.75M | -7.80M | -0.25M | |
| Change in Accured ExpensesChange Accured Exp. | 23.25M | -7.31M | 11.59M | -20.68M | 5.35M | 5.84M | -9.94M | 2.04M | 3.34M | 10.08M | -8.52M | |
| Other Working Capital ChangesOther WC Changes | 2.52M | 2.21M | -0.92M | -2.06M | 2.75M | 1.59M | 2.15M | -4.60M | 3.34M | 1.39M | -0.77M | |
| Investing Activities | ||||||||||||
| Capital ExpendituresCapex | 2.22M | 2.25M | 4.00M | 0.49M | ||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 1.62M | 0.09M | 0.19M | 0.26M | 0.13M | 0.26M | 0.22M | 0.24M | 0.01M | 0.27M | 0.31M | |
| Cash from Investing ActivitiesCash from Investing | -1.15M | -3.60M | -13.10M | -7.08M | -6.62M | -5.54M | -13.00M | -8.97M | -4.71M | -4.75M | -4.31M | |
| Financing Activities | ||||||||||||
| Other financing activitiesOther financing | 0.35M | 0.28M | 0.87M | 0.95M | 0.65M | 0.14M | 1.09M | 0.39M | 0.35M | 0.08M | 0.57M | |
| Cash from Financing ActivitiesCash from Financing | -13.28M | -5.63M | -14.66M | 44.93M | -48.27M | -2.67M | -2.11M | -1.53M | -0.76M | -2.04M | -0.81M | |
| Change in Capital Stock | ||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 29.04M | 30.28M | ||||||||||
| Dividend Payments | ||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 4.75M | 3.68M | 4.31M | 6.29M | 0.18M | 0.14M | 0.05M | 0.27M | 0.96M | 0.33M | ||
| Additional items | ||||||||||||
| Change in Cash | 0.13M | -0.58M | 1.36M | 35.68M | -32.56M | 9.34M | 4.82M | 17.67M | 29.13M | -0.73M | 24.91M | |
| Free Cash FlowFCF | 14.55M | 8.65M | 29.13M | -4.38M | 20.09M | 17.55M | 19.94M | 24.17M | 34.10M | 6.06M | 30.02M | |
| Net Cash FlowNCF | 0.13M | -0.58M | 1.36M | 35.68M | -32.56M | 9.34M | 4.82M | 17.67M | 29.13M | -0.73M | 24.91M |